Super EPO: why the discussion about doping with marine worms is resurfacing
Three years ago, alarms were raised about the possibility of using marine sandworm hemoglobin as a doping substance. Now, the Italian newspaper Il Corriere de la Sera claims that Belarusian and Chinese laboratories have developed M101, a substance that would increase the blood's capacity to transport oxygen.

Sandworm hemoglobin could already be used as a doping agent
Since the properties of sandworm hemoglobin were discovered a few years ago, capable of storing up to 156 molecules of oxygen compared to the 4 that each human hemoglobin molecule can transport, laboratories in Belarus and China have been working to develop the substance M101, which is currently authorized for use in the preservation of organs intended for transplantation.
However, the fact that M101 has the nickname Lance A, clearly referencing the American ex-cyclist, is a clear indication that the black market for this substance may already be moving and could be used for more than just organ preservation.
RECOMENDADO
New FOX Transfer Neo post of 225 mm
Eli Iserbyt ends his sports career after receiving a definitive medical diagnosis
The Decathlon Ford Racing team is betting on the Spanish brand Damoff for the maintenance of its bikes
Pidcock presents the new 2026 kit of Pinarello-Q36.5
For the first time, SRAM matches Shimano in sponsorships for World Tour teams
Overbooking at Teide: Pidcock heads to Chile for the first altitude training camp

In various experiments with hamsters injected with M101, it has been observed that their endurance and power significantly increased because their blood's capacity to transport oxygen multiplied by 10.
The problem for anti-doping authorities is that M101 does not cause variations in hematocrit levels, as traditional blood doping methods like EPO use or transfusions do, which would render the main tool that UCI and AMA currently have to detect these practices, the biological passport, ineffective.

For now, the only tool that AMA has to detect this substance would be blood tests using the non-human hemoglobin detection system, a complex and costly method. Additionally, they face the handicap that the half-life of M101 in the body is only a few hours, making the speed between blood extraction and its arrival at the laboratory for preservation essential.
Currently, in preparation for the upcoming Winter Olympics in Milan-Cortina, samples will be taken, in just half a day, to the renovated laboratory in Rome, which, like those in Lausanne and Cologne, already has the capacity to detect non-human hemoglobin in case AMA requires this type of analysis now or in the future.